David Gómez-Almaguer
2 years
Believe it or not, but this middle age lady with CLL, received FCR, BR, ibrutinib. After short response she was in a "bad" relapse. Single Venetoclax, 100 mg/day with itraconazol made this response. Monterrey, Mexico. UANL